Ethyl Nipecotate CAS 5006-62-2 Intende ≥99.0% (GC) High Quality

Description:

Chemical Name: Ethyl Nipecotate

CAS: 5006-62-2

Aspectus: Hyalina ad Pallida Liquid

Dic: ≥99.0% (GC)

High Quality, Commercial Production

E-mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Copia cum summa puritate et stabulo Quality
Chemical Name: Ethyl Nipecotate
CAS: 5006-62-2
High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Ethyl Nipecotate
Synonyma	Ethyl 3-Piperidinecarboxylata;Ethyl piperidine-3-carboxylato;3-Piperidinecarboxylic Acidum Ethyl Ester
CAS Number	5006-62-2
CATTUS Number	RF-PI271
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C8H15NO2
M. Pondus	157.21
Liquescens punctum	165.0~167.0℃
Ferveret	102-104℃ /7 mmHg (lit.)
Density	1.012 g/mL ad 25℃ (lit.)
Index refractivus	n20/D 1.460 (lit.)
Aqua Solubility	Miscible
Shipping Condition	Uit sub Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina ad Pallida Liquid
Aqua	≤0.50%
una immunditia	≤0.50%
Totalis immunditias	≤1.0%
Metalla gravis	≤20ppm
Assay	≥99.0%
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, Ferocactus, 25kg/ Ferocactus, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi Ethyl Nipecotatis (CAS: 5006-62-2) cum qualitate, late in synthesi organica, synthesi pharmaceuticae intermediorum et pharmaceuticae Ingredientis (API) synthesis activae.

Applicatio Ethyl Nipecotatis (CAS: 5006-62-2) adhibita est in synthesi: α, α′-bis[3-(N,N-diethylcarbamoyl)-piperidino]-p-xylene;2-amino-4-thiazolyl derivativum 3-(iso-propyl-3-piperidinyl) phenol;

Reactant for synthesis of: Squalene synthase inhibitores;4-aminomethyl-7,8-dihydroxycoumarines eorumque coronae aetheris derivationes;Spiroimidazolidinone NPC1L1 inhibitors;Quorum sensus modulatores;selectivam serotonin 5-HT6 receptorem diluere;Oxazolidinone rna-agentibus obligandi.